Jump to content

CLINICAL TRIALS MENTIONED In TELECONFERENCE 28 February 2014


Paul Edwards

Recommended Posts

In today's teleconference Tony Maxwell mentioned several clinical trials in relation to the drug Enzalutamide which are currently recruiting:

 

PROSPER Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

 

Click on this link for more details

 

PLATO Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients

 

Click on this link for more details

 

Alpharadin (also known as Radium-223 and Xofigo)

 

The ALSYMPCA Clinical Trial mentioned on the Prostate Cancer Foundation of Australia website is no longer recruiting participants.

 

Two new Alpharadin clinical trials are about to commence recruiting Australian  participants.

 

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

Active but not yet recruiting. Study Start Date March 2014

 

Click here for more details

 

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Active but not yet recruiting. Study Start Date March 2014

 

Click here for more details

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...